Amdocs Gains After Veon Taps Its AI Platform For Eurasia Modernization
Amdocs VEON Deal spans 10 years, expands AI modernization across Eurasia and supports VEON’s digital operator strategy.
Stocks · News reference
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Amdocs VEON Deal spans 10 years, expands AI modernization across Eurasia and supports VEON’s digital operator strategy.
Analyst ratings highlight high-yield tech stocks Opera (4.52%), Amdocs (3.81%) and Accenture (3.71%), with mixed targets and recent in-line earnings.